Autolus lifts 2026 guidance to $140–$150M, lands $75M credit facility, and pushes cash runway into 2028

summarizeSummary

Preliminary Q2 AUCATZYL revenue of ~$45 million, raised 2026 guidance to $140–$150 million, and a $75 million credit facility from Perceptive Advisors extend Autolus's cash runway into Q2 2028.

check_boxKey Events · Earnings and Guidance · AUTL

• Preliminary Q2 Revenue of ~$45M

  AUCATZYL net product revenue hit approximately $45 million in Q2 2026, a roughly 70% sequential gain over Q1 2026 and more than double the Q2 2025 figure.

• Full-Year Guidance Raised to $140–$150M

  Reflecting strong commercial momentum, management lifted 2026 AUCATZYL revenue guidance to $140–$150 million, up from the prior range of $120–$135 million.

• $75M Credit Facility Secured

  A $75 million senior secured notes facility with Perceptive Advisors was closed, with an additional $25 million available at the company's option and up to $150 million more upon achieving revenue milestones.

• Cash Runway Extended into Q2 2028

  The credit facility, combined with existing cash, is expected to fund operations into the second quarter of 2028, eliminating near-term going-concern risk.

auto_awesomeAnalysis · AUTL · Life Sciences

A trio of positive developments reshapes the outlook. Preliminary Q2 AUCATZYL revenue of roughly $45 million marks a sequential jump of about 70%, while full-year guidance climbs to $140–$150 million. A new $75 million credit facility from Perceptive Advisors, accompanied by a warrant for 3.5 million ADSs at $1.9314—a modest premium to the current $1.605 stock price—extends the cash runway into Q2 2028. The move directly addresses the going-concern risk highlighted in June, replacing it with a clear path to sustained operations and growth.